Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and Migraine Disorders

1,2,3,4-tetrahydroquinoline has been researched along with Migraine Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrews, J; Annedi, SC; Catalano, C; De Felice, M; Dove, P; Lee, DK; Maddaford, SP; Mladenova, G; Nair, S; Porreca, F; Rakhit, S; Ramnauth, J; Renton, P; Silverman, S; Speed, J; Zinghini, S1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Migraine Disorders

ArticleYear
Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors.
    Journal of medicinal chemistry, 2011, Aug-11, Volume: 54, Issue:15

    Topics: Animals; Humans; Hyperalgesia; Male; Migraine Disorders; Neuralgia; Nitric Oxide Synthase Type I; Quinolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2011